Compare Abeona Therapeutics Inc (ABEO) vs Solaredge Technologies Inc (SEDG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Solaredge Technologies Inc — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Solaredge Technologies Inc trades at $52.7 (market cap $3.22B). The key difference: Solaredge Technologies Inc is far larger — about 8.6× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Solaredge Technologies Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | SEDG | |
|---|---|---|
Market Cap | $373.32M | $3.22B |
Sector | Health | Technology |
52-Week High | $7.23 | $78.51 |
52-Week Low | $4.17 | $24.42 |
Enterprise Value | $228.22M | $3.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
SolarEdge Technologies (SEDG) trades at $52.94, up 1.07% on the day, with a bullish technical signal from moving averages and recent positive momentum in solar stocks. The company reported Q1 2026 earnings that missed expectations, with a net loss of $405.45 million on $1.18 billion revenue. Despite negative profitability metrics, SEDG has beaten earnings estimates in two of the last three quarters. Recent news highlights sector-wide gains driven by AI data center power demand and analyst optimism.
The outlook remains mixed: strong solar industry tailwinds and operational cash flow improvement offer potential upside, but persistent net losses, high debt, and competitive pressures pose significant risks. Analyst consensus is cautious with a $32.11 price target below current levels, reflecting concerns over profitability and execution challenges in a volatile market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Solaredge Technologies Inc
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →
